US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.730
  • -0.110-2.86%
Close Nov 22 16:00 ET
391.29MMarket Cap-1942P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.37%-41.09M
22.96%-41.13M
5.12%-65.94M
-11.90%-216.58M
-41.58%-42.73M
11.94%-50.96M
-20.71%-53.38M
-13.43%-69.5M
12.63%-193.55M
32.34%-30.18M
Net income from continuing operations
73.00%-38.12M
44.33%-37.47M
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-9.58%-67.32M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
Depreciation and amortization
-41.08%1.25M
-59.53%1.43M
-70.07%1.98M
-65.02%13.69M
-92.28%1.42M
-75.81%2.13M
-46.57%3.53M
23.10%6.62M
97.18%39.15M
239.14%18.38M
Other non cash items
190.12%1.97M
158.92%1.82M
-11.30%738K
-2.15%3.04M
76.27%832K
-55.07%678K
11.62%701K
66.07%832K
165.81%3.11M
396.84%472K
Change In working capital
36.40%-8.98M
-143.93%-10.85M
18.79%-23.14M
-6,698.80%-43.88M
-82.53%3.18M
-1,217.26%-14.12M
-654.61%-4.45M
-65.19%-28.49M
113.93%665K
833.80%18.18M
-Change in receivables
-45.44%-12.18M
-271.32%-6.2M
45.22%-2.21M
-104.48%-16.34M
-674.37%-2.26M
-36.29%-8.37M
-49.24%-1.67M
-259.22%-4.03M
-426.00%-7.99M
123.31%394K
-Change in inventory
45.85%-3.47M
-17.37%-4.71M
72.34%-2.11M
-148.17%-14.91M
428.09%3.16M
-103.04%-6.42M
-36.36%-4.01M
-1,418.69%-7.64M
-40.44%-6.01M
1,473.68%598K
-Change in prepaid assets
108.20%731K
23.59%-1.38M
109.49%123K
-288.79%-6.79M
15.03%5.23M
-829.41%-8.91M
-816.75%-1.81M
-720.10%-1.3M
305.37%3.6M
165.92%4.54M
-Change in payables and accrued expense
-187.06%-8.2M
89.84%4.52M
-2.76%-18.72M
-81.47%1.88M
-47.85%8.29M
115.00%9.42M
-55.36%2.38M
-17.51%-18.22M
102.28%10.12M
318.95%15.9M
-Change in other current assets
110.73%1.75M
-2,503.69%-18.89M
103.11%711K
-386.75%-35.5M
-22.65%2.87M
-398.46%-16.33M
-98.51%786K
66.97%-22.83M
49.27%-7.29M
-59.08%3.71M
-Change in other current liabilities
-113.27%-1.92M
2,819.75%19.42M
-104.01%-958K
407.87%32.07M
-19.38%-5.58M
277.80%14.45M
98.64%-714K
-66.64%23.91M
-54.18%6.31M
-294.76%-4.67M
-Change in other working capital
601.03%14.3M
-715.87%-3.61M
-98.08%31K
-322.18%-4.29M
-272.16%-8.53M
-72.67%2.04M
263.23%586K
156.03%1.62M
218.33%1.93M
-93.58%-2.29M
Cash from discontinued investing activities
Operating cash flow
19.37%-41.09M
22.96%-41.13M
5.12%-65.94M
-11.90%-216.58M
-41.58%-42.73M
11.94%-50.96M
-20.71%-53.38M
-13.43%-69.5M
12.63%-193.55M
32.34%-30.18M
Investing cash flow
Cash flow from continuing investing activities
-54.85%23.29M
82.57%-6.89M
-133.27%-31.71M
179.06%109.74M
-94.21%2.37M
143.55%51.59M
62.66%-39.53M
113.87%95.32M
-367.88%-138.8M
48.19%40.96M
Net PPE purchase and sale
98.65%-61K
1,024.81%2.99M
-494.71%-5.17M
-114.52%-6.89M
-38.12%-1.78M
-349.40%-4.5M
-50.37%266K
40.25%-870K
69.06%-3.21M
70.44%-1.29M
Net investment purchase and sale
-54.23%27.22M
88.39%-4.62M
-127.59%-26.54M
204.94%121.51M
-87.23%5.65M
154.30%59.47M
60.39%-39.8M
92.43%96.19M
-899.03%-115.79M
38.22%44.23M
Net other investing changes
---3.87M
----
----
75.34%-4.88M
24.24%-1.5M
----
----
----
-157.14%-19.8M
---1.98M
Cash from discontinued investing activities
Investing cash flow
-54.85%23.29M
82.57%-6.89M
-133.27%-31.71M
179.06%109.74M
-94.21%2.37M
143.55%51.59M
62.66%-39.53M
113.87%95.32M
-367.88%-138.8M
48.19%40.96M
Financing cash flow
Cash flow from continuing financing activities
-116.25%-6.09M
-103.50%-3.41M
2,743.12%92.83M
-58.83%136.57M
73.61%-1.63M
-82.28%37.46M
360.53%97.47M
-96.90%3.27M
1,010.50%331.69M
-1,624.20%-6.17M
Net issuance payments of debt
-113.68%-5.72M
39.25%-3.9M
-70.03%-4.23M
-65.35%30.16M
55.03%-2.74M
1,390.15%41.8M
-264.38%-6.41M
-102.53%-2.49M
--87.05M
---6.1M
Net common stock issuance
--0
--0
--97.63M
-59.61%100.18M
--0
--0
339.07%100.18M
--0
1,042.61%248.01M
--0
Proceeds from stock option exercised by employees
-91.38%5K
-87.59%557K
-99.79%20K
217.20%15.29M
-42.18%1.26M
-88.67%58K
119.19%4.49M
11,901.27%9.48M
-71.12%4.82M
31.46%2.18M
Net other financing activities
91.50%-374K
90.48%-75K
84.16%-591K
-10.64%-9.07M
93.44%-148K
-111.19%-4.4M
59.38%-788K
-94.98%-3.73M
3.89%-8.19M
-79.98%-2.26M
Cash from discontinued financing activities
Financing cash flow
-116.25%-6.09M
-103.50%-3.41M
2,743.12%92.83M
-58.83%136.57M
73.61%-1.63M
-82.28%37.46M
360.53%97.47M
-96.90%3.27M
1,010.50%331.69M
-1,624.20%-6.17M
Net cash flow
Beginning cash position
-40.47%88.5M
-2.89%139.93M
25.85%144.75M
-0.56%115.02M
69.13%186.74M
97.31%148.66M
-29.46%144.1M
-0.56%115.02M
-65.68%115.67M
-16.50%110.41M
Current changes in cash
-162.71%-23.88M
-1,228.62%-51.43M
-116.57%-4.82M
4,660.12%29.73M
-1,011.83%-41.99M
8.58%38.08M
103.53%4.56M
-67.18%29.08M
99.71%-652K
127.80%4.61M
End cash Position
-65.40%64.61M
-40.47%88.5M
-2.89%139.93M
25.85%144.75M
25.85%144.75M
69.13%186.74M
97.31%148.66M
-29.46%144.1M
-0.56%115.02M
-0.56%115.02M
Free cash flow
25.81%-41.15M
28.20%-38.14M
-1.06%-71.11M
-13.57%-223.46M
-41.44%-44.51M
5.79%-55.47M
-21.58%-53.12M
-12.19%-70.37M
15.16%-196.76M
35.73%-31.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.37%-41.09M22.96%-41.13M5.12%-65.94M-11.90%-216.58M-41.58%-42.73M11.94%-50.96M-20.71%-53.38M-13.43%-69.5M12.63%-193.55M32.34%-30.18M
Net income from continuing operations 73.00%-38.12M44.33%-37.47M11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-9.58%-67.32M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M
Depreciation and amortization -41.08%1.25M-59.53%1.43M-70.07%1.98M-65.02%13.69M-92.28%1.42M-75.81%2.13M-46.57%3.53M23.10%6.62M97.18%39.15M239.14%18.38M
Other non cash items 190.12%1.97M158.92%1.82M-11.30%738K-2.15%3.04M76.27%832K-55.07%678K11.62%701K66.07%832K165.81%3.11M396.84%472K
Change In working capital 36.40%-8.98M-143.93%-10.85M18.79%-23.14M-6,698.80%-43.88M-82.53%3.18M-1,217.26%-14.12M-654.61%-4.45M-65.19%-28.49M113.93%665K833.80%18.18M
-Change in receivables -45.44%-12.18M-271.32%-6.2M45.22%-2.21M-104.48%-16.34M-674.37%-2.26M-36.29%-8.37M-49.24%-1.67M-259.22%-4.03M-426.00%-7.99M123.31%394K
-Change in inventory 45.85%-3.47M-17.37%-4.71M72.34%-2.11M-148.17%-14.91M428.09%3.16M-103.04%-6.42M-36.36%-4.01M-1,418.69%-7.64M-40.44%-6.01M1,473.68%598K
-Change in prepaid assets 108.20%731K23.59%-1.38M109.49%123K-288.79%-6.79M15.03%5.23M-829.41%-8.91M-816.75%-1.81M-720.10%-1.3M305.37%3.6M165.92%4.54M
-Change in payables and accrued expense -187.06%-8.2M89.84%4.52M-2.76%-18.72M-81.47%1.88M-47.85%8.29M115.00%9.42M-55.36%2.38M-17.51%-18.22M102.28%10.12M318.95%15.9M
-Change in other current assets 110.73%1.75M-2,503.69%-18.89M103.11%711K-386.75%-35.5M-22.65%2.87M-398.46%-16.33M-98.51%786K66.97%-22.83M49.27%-7.29M-59.08%3.71M
-Change in other current liabilities -113.27%-1.92M2,819.75%19.42M-104.01%-958K407.87%32.07M-19.38%-5.58M277.80%14.45M98.64%-714K-66.64%23.91M-54.18%6.31M-294.76%-4.67M
-Change in other working capital 601.03%14.3M-715.87%-3.61M-98.08%31K-322.18%-4.29M-272.16%-8.53M-72.67%2.04M263.23%586K156.03%1.62M218.33%1.93M-93.58%-2.29M
Cash from discontinued investing activities
Operating cash flow 19.37%-41.09M22.96%-41.13M5.12%-65.94M-11.90%-216.58M-41.58%-42.73M11.94%-50.96M-20.71%-53.38M-13.43%-69.5M12.63%-193.55M32.34%-30.18M
Investing cash flow
Cash flow from continuing investing activities -54.85%23.29M82.57%-6.89M-133.27%-31.71M179.06%109.74M-94.21%2.37M143.55%51.59M62.66%-39.53M113.87%95.32M-367.88%-138.8M48.19%40.96M
Net PPE purchase and sale 98.65%-61K1,024.81%2.99M-494.71%-5.17M-114.52%-6.89M-38.12%-1.78M-349.40%-4.5M-50.37%266K40.25%-870K69.06%-3.21M70.44%-1.29M
Net investment purchase and sale -54.23%27.22M88.39%-4.62M-127.59%-26.54M204.94%121.51M-87.23%5.65M154.30%59.47M60.39%-39.8M92.43%96.19M-899.03%-115.79M38.22%44.23M
Net other investing changes ---3.87M--------75.34%-4.88M24.24%-1.5M-------------157.14%-19.8M---1.98M
Cash from discontinued investing activities
Investing cash flow -54.85%23.29M82.57%-6.89M-133.27%-31.71M179.06%109.74M-94.21%2.37M143.55%51.59M62.66%-39.53M113.87%95.32M-367.88%-138.8M48.19%40.96M
Financing cash flow
Cash flow from continuing financing activities -116.25%-6.09M-103.50%-3.41M2,743.12%92.83M-58.83%136.57M73.61%-1.63M-82.28%37.46M360.53%97.47M-96.90%3.27M1,010.50%331.69M-1,624.20%-6.17M
Net issuance payments of debt -113.68%-5.72M39.25%-3.9M-70.03%-4.23M-65.35%30.16M55.03%-2.74M1,390.15%41.8M-264.38%-6.41M-102.53%-2.49M--87.05M---6.1M
Net common stock issuance --0--0--97.63M-59.61%100.18M--0--0339.07%100.18M--01,042.61%248.01M--0
Proceeds from stock option exercised by employees -91.38%5K-87.59%557K-99.79%20K217.20%15.29M-42.18%1.26M-88.67%58K119.19%4.49M11,901.27%9.48M-71.12%4.82M31.46%2.18M
Net other financing activities 91.50%-374K90.48%-75K84.16%-591K-10.64%-9.07M93.44%-148K-111.19%-4.4M59.38%-788K-94.98%-3.73M3.89%-8.19M-79.98%-2.26M
Cash from discontinued financing activities
Financing cash flow -116.25%-6.09M-103.50%-3.41M2,743.12%92.83M-58.83%136.57M73.61%-1.63M-82.28%37.46M360.53%97.47M-96.90%3.27M1,010.50%331.69M-1,624.20%-6.17M
Net cash flow
Beginning cash position -40.47%88.5M-2.89%139.93M25.85%144.75M-0.56%115.02M69.13%186.74M97.31%148.66M-29.46%144.1M-0.56%115.02M-65.68%115.67M-16.50%110.41M
Current changes in cash -162.71%-23.88M-1,228.62%-51.43M-116.57%-4.82M4,660.12%29.73M-1,011.83%-41.99M8.58%38.08M103.53%4.56M-67.18%29.08M99.71%-652K127.80%4.61M
End cash Position -65.40%64.61M-40.47%88.5M-2.89%139.93M25.85%144.75M25.85%144.75M69.13%186.74M97.31%148.66M-29.46%144.1M-0.56%115.02M-0.56%115.02M
Free cash flow 25.81%-41.15M28.20%-38.14M-1.06%-71.11M-13.57%-223.46M-41.44%-44.51M5.79%-55.47M-21.58%-53.12M-12.19%-70.37M15.16%-196.76M35.73%-31.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data